GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Ending Cash Position

K Pharma (TSE:4896) Ending Cash Position : 円0 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is K Pharma Ending Cash Position?

K Pharma's Ending Cash Position for the quarter that ended in Mar. 2024 was 円0 Mil.

K Pharma's annual Ending Cash Position increased from Dec. 2021 (円189 Mil) to Dec. 2022 (円1,337 Mil) and increased from Dec. 2022 (円1,337 Mil) to Dec. 2023 (円3,266 Mil).


K Pharma Ending Cash Position Historical Data

The historical data trend for K Pharma's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

K Pharma Ending Cash Position Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23
Ending Cash Position
188.78 1,336.85 3,266.41

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial - - - - -

K Pharma Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

K Pharma's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1336.847+1929.561
=3,266

K Pharma's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0


K Pharma Ending Cash Position Related Terms

Thank you for viewing the detailed overview of K Pharma's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


K Pharma (TSE:4896) Business Description

Traded in Other Exchanges
N/A
Address
7-7-7 Roppongi, Minato-ku, Tokyo, JPN, 106-0032
K Pharma Inc is a company involved in Research, development, manufacturing, sales and marketing of pharmaceutical products and regenerative medicine products. It is involved in studying of iPs cells in regnerative medecine to treat neurological conditions such as cerebral infarction and SCI.

K Pharma (TSE:4896) Headlines

No Headlines